{"id":"azithromycin-on-day-1","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Nausea"},{"rate":"5-10","effect":"Diarrhea"},{"rate":"3-8","effect":"Abdominal pain"},{"rate":"2-5","effect":"Vomiting"},{"rate":"rare","effect":"QT prolongation"},{"rate":"rare","effect":"Hepatotoxicity"}]},"_chembl":{"chemblId":"CHEMBL4299381","moleculeType":"Small molecule","molecularWeight":"749.00"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Azithromycin is a macrolide antibiotic that binds irreversibly to the bacterial 50S ribosomal subunit, blocking translocation of peptides and inhibiting protein synthesis. This bacteriostatic action prevents bacterial replication and allows the immune system to clear the infection. It also has immunomodulatory properties that may reduce inflammation in certain respiratory conditions.","oneSentence":"Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and halting bacterial growth.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:03:17.991Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial respiratory tract infections (community-acquired pneumonia, bronchitis)"},{"name":"Sexually transmitted infections (chlamydia, gonorrhea)"},{"name":"Skin and soft tissue infections"},{"name":"Otitis media"}]},"trialDetails":[{"nctId":"NCT04185402","phase":"PHASE4","title":"Azithromycin Reduction to Reach Elimination of Trachoma","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2021-05-29","conditions":"Trachoma","enrollment":3931},{"nctId":"NCT05994742","phase":"PHASE3","title":"An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Queen Mary University of London","startDate":"2024-07-15","conditions":"Severe Acute Malnutrition, HIV, Comorbidities and Coexisting Conditions","enrollment":674},{"nctId":"NCT06289647","phase":"PHASE4","title":"Azithromycin Reduction to Reach Elimination of Trachoma B","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2024-10","conditions":"Trachoma","enrollment":""},{"nctId":"NCT03083197","phase":"PHASE4","title":"Scrub Typhus Antibiotic Resistance Trial","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2017-10-15","conditions":"Scrub Typhus","enrollment":177},{"nctId":"NCT07306234","phase":"PHASE4","title":"Doxycycline vs. Macrolide for MRMP (DOMINO)","status":"NOT_YET_RECRUITING","sponsor":"Young June Choe","startDate":"2026-03-01","conditions":"Mycoplasma Pneumoniae, Mycoplasma Pneumoniae Pneumonia","enrollment":208},{"nctId":"NCT06468462","phase":"PHASE4","title":"Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-10-29","conditions":"Gonorrhea Male, Chlamydia (Male), Syphilis Male","enrollment":2900},{"nctId":"NCT07148622","phase":"NA","title":"Effects of Different Antibiotic Regimens in Preterm Premature Rupture of Membranes","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2024-10-01","conditions":"Preterm Premature Rupture of Membranes (PPROM), Prophylaxis, Perinatal Outcomes","enrollment":40},{"nctId":"NCT03273296","phase":"PHASE4","title":"Effect of Antibiotics on Gut Microbiome and Plasma Metabolome","status":"COMPLETED","sponsor":"Finnish Institute for Health and Welfare","startDate":"2017-10-15","conditions":"Microbial Colonization","enrollment":39},{"nctId":"NCT07064278","phase":"NA","title":"Combined Diagnostic Approach for Refractory Mycoplasma Pneumonia in Children","status":"COMPLETED","sponsor":"Children's Hospital of Hebei Province","startDate":"2022-12-01","conditions":"Refractory Mycoplasma Pneumoniae Pneumonia","enrollment":260},{"nctId":"NCT03479736","phase":"","title":"A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-11-20","conditions":"Retinal Detachment, Achilles Tendon, Aneurysm, Dissecting","enrollment":117911},{"nctId":"NCT03162497","phase":"PHASE4","title":"Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2018-01-08","conditions":"Dry Eye Syndromes, Meibomian Gland Dysfunction","enrollment":23},{"nctId":"NCT06325293","phase":"NA","title":"A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study","status":"RECRUITING","sponsor":"Christoph Berger","startDate":"2025-01-28","conditions":"Community Acquired Pneumonia in Children, Mycoplasma Pneumoniae, Mycoplasma Pneumoniae Pneumonia","enrollment":376},{"nctId":"NCT04198649","phase":"PHASE3","title":"Effect of Azithromycin on Failure Proportion of Severe Periodontitis Non-surgical Treatment","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2021-11-02","conditions":"Severe Chronic Periodontitis","enrollment":6},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04527016","phase":"PHASE4","title":"Airway Microbiota Based Treatment of Asthma in Preschool Children","status":"COMPLETED","sponsor":"Children's Hospital of Fudan University","startDate":"2021-10-18","conditions":"Asthma in Children","enrollment":120},{"nctId":"NCT05966688","phase":"PHASE1","title":"A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy Participants","status":"COMPLETED","sponsor":"Spero Therapeutics","startDate":"2023-08-04","conditions":"Healthy Volunteers","enrollment":39},{"nctId":"NCT03160638","phase":"PHASE2","title":"Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2018-02-01","conditions":"Tuberculosis, Pulmonary","enrollment":24},{"nctId":"NCT06199440","phase":"PHASE1, PHASE2","title":"Azithromycin Versus Doxycycline on Restistin Level in Periodontitis Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"King Abdulaziz University","startDate":"2022-06-01","conditions":"Periodontal Diseases, Type 2 Diabetes","enrollment":15},{"nctId":"NCT04381936","phase":"PHASE3","title":"Randomised Evaluation of COVID-19 Therapy","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2020-03-19","conditions":"Severe Acute Respiratory Syndrome","enrollment":70000},{"nctId":"NCT04458948","phase":"PHASE2","title":"Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients","status":"TERMINATED","sponsor":"University of New Mexico","startDate":"2020-03-24","conditions":"COVID-19","enrollment":28},{"nctId":"NCT03341273","phase":"NA","title":"Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin Level","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-12-08","conditions":"Lower Respiratory Tract Infection","enrollment":514},{"nctId":"NCT04371107","phase":"PHASE3","title":"Proactive Care of Ambulatory COVID19 Patients","status":"SUSPENDED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2020-04-29","conditions":"Covid19, Azithromycin, Ambulatory","enrollment":11},{"nctId":"NCT04613271","phase":"PHASE3","title":"Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia","status":"COMPLETED","sponsor":"Ina-Respond","startDate":"2020-10-15","conditions":"Infectious Disease, SARS-CoV Infection, Covid19","enrollment":130},{"nctId":"NCT03187834","phase":"PHASE4","title":"Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2017-07-04","conditions":"Child Development","enrollment":252},{"nctId":"NCT04336332","phase":"PHASE2","title":"Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19","status":"TERMINATED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2020-04-01","conditions":"SARS-CoV-2, COVID-19","enrollment":75},{"nctId":"NCT03683667","phase":"PHASE2, PHASE3","title":"Protein Plus: Improving Infant Growth Through Diet and Enteric Health","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2018-09-23","conditions":"Stunting, Malnutrition; Protein, Enteric Pathogens","enrollment":5283},{"nctId":"NCT03098485","phase":"NA","title":"Healthy Patients & Effect of Antibiotics","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-01","conditions":"Microbiota, Anti-bacterial Agents","enrollment":20},{"nctId":"NCT03570814","phase":"PHASE4","title":"Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2021-12-01","conditions":"Trachoma, Lymphatic Filariases","enrollment":13511},{"nctId":"NCT04354428","phase":"PHASE2, PHASE3","title":"Treatment for COVID-19 in High-Risk Adult Outpatients","status":"TERMINATED","sponsor":"University of Washington","startDate":"2020-04-16","conditions":"COVID-19, SARS-CoV-2","enrollment":289},{"nctId":"NCT04329832","phase":"PHASE2","title":"Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19","status":"COMPLETED","sponsor":"Intermountain Health Care, Inc.","startDate":"2020-03-30","conditions":"COVID-19","enrollment":85},{"nctId":"NCT05302947","phase":"","title":"COVID-19 Study at the Russian Clinical and Research Center of Gerontology of the Pirogov RNRMU","status":"COMPLETED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2020-02-01","conditions":"COVID-19, Mild to Moderate","enrollment":154},{"nctId":"NCT04338698","phase":"PHASE3","title":"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT","status":"COMPLETED","sponsor":"Shehnoor Azhar","startDate":"2020-04-22","conditions":"COVID 19","enrollment":550},{"nctId":"NCT04344444","phase":"PHASE3","title":"Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease","status":"TERMINATED","sponsor":"LCMC Health","startDate":"2020-04-13","conditions":"COVID-19","enrollment":22},{"nctId":"NCT05151614","phase":"PHASE1","title":"Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection","status":"COMPLETED","sponsor":"University of Baghdad","startDate":"2021-04-01","conditions":"COVID-19 Pandemic","enrollment":160},{"nctId":"NCT04358068","phase":"PHASE2","title":"Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-05-13","conditions":"COVID-19, SARS-CoV 2","enrollment":20},{"nctId":"NCT05118984","phase":"PHASE4","title":"Efficacy of Azithromycin in MSAF Cases to Improve Maternal and Neonatal Outcomes","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-02-16","conditions":"Meconium Stained, Azithromycin, Postpartum Endometritis","enrollment":324},{"nctId":"NCT05026801","phase":"PHASE3","title":"Azithromycin Plus Hydroxychloroquine for COVID-19 Infection","status":"WITHDRAWN","sponsor":"Iterum Therapeutics, International Limited","startDate":"2021-02-08","conditions":"Respiratory Tract Infection Viral","enrollment":""},{"nctId":"NCT04354597","phase":"NA","title":"Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients","status":"WITHDRAWN","sponsor":"King Hussein Cancer Center","startDate":"2020-05-01","conditions":"COVID-19","enrollment":""},{"nctId":"NCT04346693","phase":"PHASE3","title":"An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19","status":"COMPLETED","sponsor":"Burnasyan Federal Medical Biophysical Center","startDate":"2020-04-08","conditions":"Acute Respiratory Tract Infection, Acute Respiratory Insufficiency, Pneumonia","enrollment":320},{"nctId":"NCT04869579","phase":"PHASE2","title":"Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.","status":"UNKNOWN","sponsor":"CHRISTUS Health","startDate":"2021-08-15","conditions":"Covid19","enrollment":100},{"nctId":"NCT04394377","phase":"PHASE4","title":"Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial","status":"COMPLETED","sponsor":"Brazilian Clinical Research Institute","startDate":"2020-06-21","conditions":"Coronavirus Infection","enrollment":615},{"nctId":"NCT04335552","phase":"PHASE2","title":"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection","status":"TERMINATED","sponsor":"Duke University","startDate":"2020-04-17","conditions":"SARS-CoV-2","enrollment":11},{"nctId":"NCT04871633","phase":"NA","title":"Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore","status":"COMPLETED","sponsor":"King Edward Medical University","startDate":"2020-08-01","conditions":"COVID-19","enrollment":66},{"nctId":"NCT04160026","phase":"PHASE4","title":"Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2019-11-11","conditions":"Malaria in Pregnancy, Adherence, Treatment","enrollment":1600},{"nctId":"NCT04150250","phase":"PHASE2","title":"Cholera Anti-Secretory Treatment Trial","status":"COMPLETED","sponsor":"PATH","startDate":"2019-11-04","conditions":"Cholera","enrollment":47},{"nctId":"NCT04349592","phase":"NA","title":"Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19","status":"COMPLETED","sponsor":"Hamad Medical Corporation","startDate":"2020-04-14","conditions":"Covid19","enrollment":456},{"nctId":"NCT04715295","phase":"PHASE4","title":"Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19","status":"UNKNOWN","sponsor":"Yaounde Central Hospital","startDate":"2020-10-05","conditions":"COVID-19","enrollment":200},{"nctId":"NCT04386447","phase":"PHASE2","title":"Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19","status":"WITHDRAWN","sponsor":"Azienda Ospedaliero-Universitaria di Parma","startDate":"2020-09-01","conditions":"Covid-19, Corona Virus Infection, SARS-CoV 2","enrollment":""},{"nctId":"NCT04047849","phase":"PHASE4","title":"Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA","status":"RECRUITING","sponsor":"Woman's","startDate":"2019-08-28","conditions":"Rupture of Membranes; Delayed Delivery (Following Spontaneous Rupture), Rupture of Membranes; Premature, Rupture of Membranes; Premature, Affecting Fetus","enrollment":34},{"nctId":"NCT03608774","phase":"PHASE4","title":"Trial of Azithromycin vs. Doxycycline for the Treatment of Rectal Chlamydia in MSM","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-07-13","conditions":"Anal Chlamydia Infection","enrollment":177},{"nctId":"NCT04370782","phase":"PHASE4","title":"Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting","status":"COMPLETED","sponsor":"St. Francis Hospital, New York","startDate":"2020-04-28","conditions":"COVID-19","enrollment":18},{"nctId":"NCT04349410","phase":"PHASE2, PHASE3","title":"The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol","status":"COMPLETED","sponsor":"The Camelot Foundation","startDate":"2020-04-11","conditions":"CoVid 19 Positive","enrollment":1800},{"nctId":"NCT04542694","phase":"PHASE3","title":"Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19","status":"COMPLETED","sponsor":"Promomed, LLC","startDate":"2020-05-21","conditions":"COVID-19","enrollment":200},{"nctId":"NCT04463420","phase":"NA","title":"Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19","status":"UNKNOWN","sponsor":"Baqiyatallah Medical Sciences University","startDate":"2020-08-15","conditions":"COVID-19","enrollment":224},{"nctId":"NCT04374552","phase":"PHASE2","title":"Asymptomatic COVID-19 Trial","status":"WITHDRAWN","sponsor":"Rutgers, The State University of New Jersey","startDate":"2020-05-05","conditions":"SARS-CoV-2 Infection","enrollment":""},{"nctId":"NCT04395768","phase":"PHASE2","title":"International ALLIANCE Study of Therapies to Prevent Progression of COVID-19","status":"UNKNOWN","sponsor":"National Institute of Integrative Medicine, Australia","startDate":"2020-09-09","conditions":"COVID19","enrollment":200},{"nctId":"NCT04530422","phase":"PHASE3","title":"Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment","status":"COMPLETED","sponsor":"Almaza Military Fever Hospital","startDate":"2020-04-15","conditions":"Covid19","enrollment":250},{"nctId":"NCT03386227","phase":"NA","title":"Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2018-01-21","conditions":"Assisted Reproductive Technology, Antibiotic Prophylaxis, Embryo Transfer","enrollment":96},{"nctId":"NCT04502342","phase":"PHASE2","title":"Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients","status":"UNKNOWN","sponsor":"Institute for Research and Development of Medicinal and Food Plants of Guinea","startDate":"2020-06-01","conditions":"Covid19","enrollment":30},{"nctId":"NCT04501965","phase":"PHASE2","title":"Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients","status":"UNKNOWN","sponsor":"Institute for Research and Development of Medicinal and Food Plants of Guinea","startDate":"2020-06-01","conditions":"Covid19","enrollment":231},{"nctId":"NCT04395170","phase":"PHASE2, PHASE3","title":"Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.","status":"UNKNOWN","sponsor":"Lifefactors Zona Franca, SAS","startDate":"2020-09","conditions":"Coronavirus Disease 2019 (COVID-19)","enrollment":75},{"nctId":"NCT04461925","phase":"PHASE1, PHASE2","title":"Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs","status":"UNKNOWN","sponsor":"Institute of Cell Therapy","startDate":"2020-05-02","conditions":"COVID-19 Pneumonia","enrollment":30},{"nctId":"NCT04441424","phase":"NA","title":"Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients","status":"COMPLETED","sponsor":"Alkarkh Health Directorate-Baghdad","startDate":"2020-04-03","conditions":"IMMUNOTHERAPY","enrollment":49},{"nctId":"NCT04363203","phase":"PHASE3","title":"VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)","status":"SUSPENDED","sponsor":"Salomeh Keyhani MD","startDate":"2020-04-30","conditions":"SARS-CoV-2, COVID-19","enrollment":300},{"nctId":"NCT04341870","phase":"PHASE2, PHASE3","title":"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO","status":"SUSPENDED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04-11","conditions":"COVID19, SARS-CoV-2 Infection","enrollment":27},{"nctId":"NCT04363060","phase":"PHASE3","title":"Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit","status":"UNKNOWN","sponsor":"Nantes University Hospital","startDate":"2020-04-30","conditions":"COVID-19 Pneumonia","enrollment":104},{"nctId":"NCT04355052","phase":"PHASE3","title":"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to \"no Treatment\" in SARS CoV 2 Virus","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2020-04-11","conditions":"COVID - 19","enrollment":250},{"nctId":"NCT04341207","phase":"PHASE2","title":"Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients","status":"UNKNOWN","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2020-04-03","conditions":"Cancer & COVID 19","enrollment":1000},{"nctId":"NCT04334382","phase":"PHASE3","title":"Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19","status":"UNKNOWN","sponsor":"Intermountain Health Care, Inc.","startDate":"2020-04-02","conditions":"COVID-19","enrollment":1550},{"nctId":"NCT04328272","phase":"PHASE3","title":"Effectiveness of Hydroxychloroquine in Covid-19 Patients","status":"UNKNOWN","sponsor":"Prof. Dr. Umar Farooq","startDate":"2020-03-28","conditions":"COVID19","enrollment":75},{"nctId":"NCT02775617","phase":"PHASE4","title":"Azithromycin - Ivermectin Mass Drug Administration for Skin Disease","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2016-07","conditions":"Scabies, Yaws, Impetigo","enrollment":1291},{"nctId":"NCT03960216","phase":"NA","title":"Effects of Periodontal Therapy in Patients With Metabolic Syndrome","status":"COMPLETED","sponsor":"Universidad Complutense de Madrid","startDate":"2012-11-28","conditions":"Periodontitis, Metabolic Syndrome","enrollment":60},{"nctId":"NCT03948620","phase":"","title":"Macrolide in Pregnancy and Adverse Child Outcomes","status":"COMPLETED","sponsor":"Institute of Child Health","startDate":"1990-01-01","conditions":"Infection","enrollment":726274},{"nctId":"NCT03676140","phase":"PHASE3","title":"Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )","status":"COMPLETED","sponsor":"Lihir Medical Centre","startDate":"2018-10-01","conditions":"Trachoma, Yaws, Lymphatic Filariases","enrollment":20000},{"nctId":"NCT01712711","phase":"PHASE2","title":"Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-09","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":40},{"nctId":"NCT01654549","phase":"PHASE2","title":"Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-04","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":40},{"nctId":"NCT03571230","phase":"PHASE4","title":"Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2018-07-01","conditions":"Helicobacter Pylori Infection, Antimicrobial Susceptibility Testing","enrollment":400},{"nctId":"NCT02630394","phase":"PHASE1","title":"A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell Disease","status":"WITHDRAWN","sponsor":"University of Mississippi Medical Center","startDate":"2015-09","conditions":"Sickle Cell Disease, Acute Chest Syndrome","enrollment":""},{"nctId":"NCT00803452","phase":"PHASE4","title":"Lipids of the Human Tear Film and Their Effect on Tear Stability","status":"COMPLETED","sponsor":"University of Louisville","startDate":"2008-07","conditions":"Blepharitis","enrollment":31},{"nctId":"NCT00549445","phase":"","title":"Effect of Macrolide Antibiotics on Airway Inflammation in People With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2007-08","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":53},{"nctId":"NCT02708992","phase":"PHASE1","title":"Cefixime / Azithromycin pK Study","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-04-28","conditions":"Gonorrhoea","enrollment":10},{"nctId":"NCT02115516","phase":"PHASE1","title":"Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis","status":"COMPLETED","sponsor":"Sanaria Inc.","startDate":"2014-04","conditions":"Malaria, Plasmodium Falciparum Malaria","enrollment":67},{"nctId":"NCT00708799","phase":"PHASE2","title":"Efficacy of Macrolide Immunomodulation in Severe Sepsis.","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2007-11","conditions":"Systemic Inflammatory Response Syndrome","enrollment":100},{"nctId":"NCT01074554","phase":"PHASE1, PHASE2","title":"Trial of Antimycobacterial Therapy in Sarcoidosis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2010-02","conditions":"Sarcoidosis","enrollment":30},{"nctId":"NCT00214331","phase":"","title":"Pharmacokinetics and Pharmacodynamics and Selected Antibiotics During Pregnancy","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2003-04","conditions":"Pregnancy","enrollment":150},{"nctId":"NCT02926326","phase":"PHASE1","title":"The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Mereo BioPharma","startDate":"2016-09","conditions":"Interaction","enrollment":16},{"nctId":"NCT01797107","phase":"PHASE2","title":"Study to Determine the Effect of Azasite on Corneal Surface Irregularity","status":"WITHDRAWN","sponsor":"Philadelphia Eye Associates","startDate":"2013-03","conditions":"Meibomian Gland Dysfunction","enrollment":""},{"nctId":"NCT02830230","phase":"NA","title":"\"Performance of HPV DNA Test in Presence of Co-infection With Common RTIs\"","status":"UNKNOWN","sponsor":"Tata Memorial Hospital","startDate":"2016-07","conditions":"Cervical Inflammation and Human Papilloma Virus Performance","enrollment":508},{"nctId":"NCT02269644","phase":"PHASE3","title":"A P3 Comparator Trial in Community Acquired Bacterial Pneumonia","status":"WITHDRAWN","sponsor":"Durata Therapeutics Inc., an affiliate of Allergan plc","startDate":"2015-11","conditions":"Community Acquired Pneumonia","enrollment":""},{"nctId":"NCT01915082","phase":"PHASE4","title":"Peri-operative Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2013-09","conditions":"Disorder Related to Lung Transplantation","enrollment":70},{"nctId":"NCT00245453","phase":"PHASE4","title":"Outpatient Registry Trial of Respiratory Tract Infections in Adults","status":"WITHDRAWN","sponsor":"CPL Associates","startDate":"2005-10","conditions":"Pneumonia, Bacterial, Bronchitis, Chronic","enrollment":""},{"nctId":"NCT01783340","phase":"PHASE1, PHASE2","title":"Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin Prophylaxis","status":"WITHDRAWN","sponsor":"Radboud University Medical Center","startDate":"2013-04","conditions":"Malaria, Falciparum","enrollment":""},{"nctId":"NCT02023554","phase":"NA","title":"Drug Interaction Study of Azithromycin and Theophylline","status":"COMPLETED","sponsor":"Zhujiang Hospital","startDate":"2013-12","conditions":"Chronic Obstructive Pulmonary Disease, Asthma","enrollment":40},{"nctId":"NCT00379821","phase":"PHASE3","title":"Chloroquine Alone or in Combination for Malaria in Children in Malawi","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2007-02","conditions":"Plasmodium Falciparum Infection","enrollment":640},{"nctId":"NCT00677833","phase":"PHASE2, PHASE3","title":"Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-06","conditions":"Malaria, Falciparum","enrollment":361},{"nctId":"NCT01903057","phase":"PHASE4","title":"Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis","status":"WITHDRAWN","sponsor":"Emory University","startDate":"2014-02","conditions":"Trachoma, Lymphatic Filariasis","enrollment":""},{"nctId":"NCT02126267","phase":"NA","title":"Evaluation of Techniques for Scaling and Root Planing and One Stage Full Mouth Disinfection","status":"COMPLETED","sponsor":"Centro Universitario de Lavras","startDate":"2013-01","conditions":"Periodontal Disease, Chronic Periodontitis","enrollment":77},{"nctId":"NCT01783860","phase":"PHASE2","title":"Oral Azithromycin Versus Doxycycline in Posterior Blepharitis","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2013-01","conditions":"Posterior Blepharitis","enrollment":100},{"nctId":"NCT00105469","phase":"PHASE3","title":"Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-07","conditions":"Bacterial Conjunctivitis","enrollment":743},{"nctId":"NCT01921738","phase":"PHASE2","title":"The Effect of Azithromycin in the Treatment of Chronic Periodontitis","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2012-05","conditions":"Chronic Periodontitis","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":90,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Zithromax"],"phase":"phase_3","status":"active","brandName":"Azithromycin on Day 1","genericName":"Azithromycin on Day 1","companyName":"Lihir Medical Centre","companyId":"lihir-medical-centre","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and halting bacterial growth. Used for Bacterial respiratory tract infections (community-acquired pneumonia, bronchitis), Sexually transmitted infections (chlamydia, gonorrhea), Skin and soft tissue infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}